A study published today in the journal Nicotine and Tobacco Research, highlights the relative safety of smokeless tobacco products and how switching to the products from combustible cigarettes was associates with lower cardiovascular disease risk in smokers.
The study, “Associations of Smokeless Tobacco Use With Cardiovascular Disease Risk: Insights From the Population Assessment of Tobacco and Health Study” was conducted by a team of researchers from UCLA, UC San Francisco, Boston University and the University of Texas at Arlington.
The researchers analyzed data from a nationally representative group of 4,347 adults who provided urine and blood samples in 2013–14 as part of the Population Assessment of Tobacco and Health (PATH) Study. Among this group, 3,034 participants used cigarettes exclusively, 338 used only smokeless tobacco, and 975 had never used any tobacco product.
The research team analysed the participants’ samples for biomarkers of tobacco exposure, inflammation and oxidative stress, which are predictors of cardiovascular disease risk, in each of the three subgroups.
Diane Caruana – VapingPost – 2022-07-28